PJ

Prashant Jayendrasingh Rajput

Active Director Director DIN 08751334
DIN 08751334 First appointment Jun 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Total affiliations 6 Since Jun 2020
Shareholding value •••• Premium profile

About Prashant Jayendrasingh Rajput

Data last updated:

Prashant Jayendrasingh Rajput is a Director at Advanced Transplant Diagnostics And Immunogenetics Private Limited (since 2020), Director at Atdi Lab Private Limited (since 2021) and Director at Advanced Renal Replacement Therapies Center Private Limited (since 2023), and holds 3 more current directorships. The companies operate in Healthcare, Non-Profit Organizations and Agriculture. The 4 current companies with reported revenue have a combined latest revenue of ₹5.48 Cr; the largest is Advanced Transplant Diagnostics And Immunogenetics Private Limited at ₹2.72 Cr (FY 2025).

DIN 08751334
Primary Designation Director
Industry Healthcare
First Appointment 02 Jun 2020
Oldest Company Age 7 yrs
Combined revenue ₹5.48 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Nov 20202019₹2.72 Cr (FY 2025)Active
Atdi Lab Private Limited U85300MH2020PTC351304
Director15 Mar 20212020₹2.09 Cr (FY 2025)Active
Director25 Mar 20232023₹65 Lakh (FY 2025)Active
Director02 Jun 20202020₹2.4 Lakh (FY 2024)Active
Director24 May 20242024Active
Director05 Jan 20242024Active

Directorship timeline

Open interactive timeline →
La Naturelle Ferme India Private Limited
Maxxfresh Agro Farmer Producer Company Limited
Atdi Lab Private Limited
Advanced Transplant Diagnostics And Immunogenetics Private Limited
Premium access

Shareholding and investment profile for Prashant Jayendrasingh Rajput

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prashant Jayendrasingh Rajput

Prashant Jayendrasingh Rajput currently holds 6 directorships: Advanced Transplant Diagnostics And Immunogenetics Private Limited (Director, since 06 Nov 2020, revenue ₹2.72 Cr (FY 2025)); Atdi Lab Private Limited (Director, since 15 Mar 2021, revenue ₹2.09 Cr (FY 2025)); Advanced Renal Replacement Therapies Center Private Limited (Director, since 25 Mar 2023, revenue ₹65 Lakh (FY 2025)); Maxxfresh Agro Farmer Producer Company Limited (Director, since 02 Jun 2020, revenue ₹2.4 Lakh (FY 2024)); Atdi Sambhaji Nagar Lab Private Limited (Director, since 24 May 2024); and 1 more.

Prashant Jayendrasingh Rajput was first appointed on 02 Jun 2020 as Director at Maxxfresh Agro Farmer Producer Company Limited. The most recent appointment on record is 24 May 2024 at Atdi Sambhaji Nagar Lab Private Limited.

The 4 current companies of Prashant Jayendrasingh Rajput that report revenue have a combined latest revenue of ₹5.48 Cr: Advanced Transplant Diagnostics And Immunogenetics Private Limited ₹2.72 Cr (FY 2025); Atdi Lab Private Limited ₹2.09 Cr (FY 2025); Advanced Renal Replacement Therapies Center Private Limited ₹65 Lakh (FY 2025); Maxxfresh Agro Farmer Producer Company Limited ₹2.4 Lakh (FY 2024).

The current boards of Prashant Jayendrasingh Rajput's companies include Bharat Vallabhdas Shah (Advanced Transplant Diagnostics And Immunogenetics Private Limited), Hepal Mihir Vora (Advanced Transplant Diagnostics And Immunogenetics Private Limited), Shruti Niranjan Tapiawala (Advanced Transplant Diagnostics And Immunogenetics Private Limited), Zaheer Aminmohamed Virani (Advanced Transplant Diagnostics And Immunogenetics Private Limited), Ishan Kishor Parekh (Advanced Renal Replacement Therapies Center Private Limited), Kamal Chokshi Chandrakant (Advanced Renal Replacement Therapies Center Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available